Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Epileptiform discharge upregulates p-ERK1/2, growth-associated protein 43 and synaptophysin in cultured rat hippocampal neurons.

Xu ZC, Chen YM, Xu P, Liu H, Xie YL, Zeng KB.

Seizure. 2009 Dec;18(10):680-5. doi: 10.1016/j.seizure.2009.09.004. Epub 2009 Oct 12.

2.

Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.

Umathe SN, Manna SS, Utturwar KS, Jain NS.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1191-9. doi: 10.1016/j.pnpbp.2009.06.020. Epub 2009 Jul 4.

PMID:
19580839
3.

Pro-drugs for indirect cannabinoids as therapeutic agents.

Ashton J.

Curr Drug Deliv. 2008 Oct;5(4):243-7.

PMID:
18855592
4.

Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.

Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.

Biol Psychiatry. 2008 Dec 1;64(11):930-7. doi: 10.1016/j.biopsych.2008.08.008. Epub 2008 Sep 23.

5.

Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia.

Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, Chapuy E, Libert F, Eschalier A.

Pain. 2008 Sep 30;139(1):190-200. doi: 10.1016/j.pain.2008.03.030. Epub 2008 May 15.

PMID:
18485596
6.

The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors.

Dani M, Guindon J, Lambert C, Beaulieu P.

Eur J Pharmacol. 2007 Nov 14;573(1-3):214-5. Epub 2007 Jul 13.

PMID:
17651722
7.

Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.

Deshpande LS, Blair RE, Nagarkatti N, Sombati S, Martin BR, DeLorenzo RJ.

Exp Neurol. 2007 Apr;204(2):705-13. Epub 2007 Jan 9.

8.

Endocannabinoids block status epilepticus in cultured hippocampal neurons.

Deshpande LS, Blair RE, Ziobro JM, Sombati S, Martin BR, DeLorenzo RJ.

Eur J Pharmacol. 2007 Mar 8;558(1-3):52-9. Epub 2006 Nov 22.

9.

Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.

Deshpande LS, Sombati S, Blair RE, Carter DS, Martin BR, DeLorenzo RJ.

Neurosci Lett. 2007 Jan 3;411(1):11-6. Epub 2006 Nov 15.

10.

The endocannabinoid system controls key epileptogenic circuits in the hippocampus.

Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wölfel B, Dodt HU, Zieglgänsberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B.

Neuron. 2006 Aug 17;51(4):455-66.

11.

Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.

Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ.

J Pharmacol Exp Ther. 2006 Jun;317(3):1072-8. Epub 2006 Feb 9.

12.

The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.

Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A.

Eur J Pharmacol. 2006 Feb 15;531(1-3):280-1. Epub 2006 Jan 24.

PMID:
16438952
13.

Cannabinoid receptors as therapeutic targets.

Mackie K.

Annu Rev Pharmacol Toxicol. 2006;46:101-22. Review.

PMID:
16402900
14.

A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.

Solbrig MV, Adrian R, Baratta J, Piomelli D, Giuffrida A.

Exp Neurol. 2005 Aug;194(2):355-62.

PMID:
16022863
15.

Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system.

Högestätt ED, Jönsson BA, Ermund A, Andersson DA, Björk H, Alexander JP, Cravatt BF, Basbaum AI, Zygmunt PM.

J Biol Chem. 2005 Sep 9;280(36):31405-12. Epub 2005 Jun 29.

16.

Status epilepticus increases the intracellular accumulation of GABAA receptors.

Goodkin HP, Yeh JL, Kapur J.

J Neurosci. 2005 Jun 8;25(23):5511-20.

17.

Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Delorenzo RJ, Sun DA, Deshpande LS.

Pharmacol Ther. 2005 Mar;105(3):229-66. Epub 2004 Dec 9. Review. Erratum in: Pharmacol Ther. 2006 Jul;111(1):287. Corrected and republished in: Pharmacol Ther. 2006 Jul;111(1):288-325.

18.

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.

Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ.

J Pharmacol Exp Ther. 2003 Oct;307(1):129-37. Epub 2003 Sep 3.

19.

Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures.

Chen K, Ratzliff A, Hilgenberg L, Gulyás A, Freund TF, Smith M, Dinh TP, Piomelli D, Mackie K, Soltesz I.

Neuron. 2003 Aug 14;39(4):599-611.

20.

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ.

Eur J Pharmacol. 2001 Sep 28;428(1):51-7.

PMID:
11779037

Supplemental Content

Support Center